How to Obtain AMA
PRA Category 1
Credit(s)™
- Read the provided journal article and slides.
- Listen to the
audio discussion.
- Login to your account.
- Complete the registration / evaluation form.
- Print your personalized
CME certificate.
Rheumatology
Online CME
Survey
|
|
|
Cardiovascular Disease in Patients With Rheumatoid Arthritis:
Results From the QUEST-RA Study
Publication: Naranjo A et al. Arthritis Res Ther. 2008;10:R30.
|
| |
| Release Date: August 13, 2008 |
Renewal Date: August 27, 2009 |
Expiration Date: August 27, 2010 |
| Estimated Time of Completion |
45 minutes |
| Description / Overview |
This archived activity is a recording of the live activity that took place on June 25, 2008. The purpose of this activity is to examine the factors associated with cardiovascular morbidity (CV) and mortality in patients with rheumatoid arthritis (RA) and recognize the importance of monitoring and treatment with disease modifying antirheumatic drugs (DMARDs). |
| Objectives |
At the conclusion of this activity, the participant will be able to:
- Identify factors associated with increased risk of CV events in patients with RA
- Outline the effects of DMARD exposure on CV morbidity, including myocardial infarction and stroke
- Discuss the importance of analyzing data from RA patients in standard clinical practice
|
| Target Audience |
This activity will be directed to physicians, nurse practitioners, physician assistants, and other health care professionals interested in RA. |
| Accreditation |
The Cleveland Clinic Foundation Center for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The Cleveland Clinic Foundation Center for Continuing Education designates this educational activity for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
This activity may be submitted for American Osteopathic Association Continuing Medical Education credit in Category 2. |
| Activity Director |
Leonard H. Calabrese, DO
Professor of Medicine
Cleveland Clinic Lerner College of Medicine of Case Western Reserve University
Vice Chairman
Department of Rheumatic & Immunologic Diseases
R.J. Fasenmyer Chair of Clinical Immunology
Cleveland Clinic
Cleveland, Ohio |
| Author / Faculty |
Theodore Pincus, MD
Director, Outcomes Research
Department of Rheumatology
New York University Hospital for Joint Diseases
New York, New York |
| Faculty Disclosure |
In accordance with the Standards for Commercial Support issued by the Accreditation Council for Continuing Medical Education (ACCME), The Cleveland Clinic Foundation Center for Continuing Education requires resolution of all faculty conflicts of interest to ensure CME activities are free of commercial bias.The following faculty has indicated that he may have a relationship, which in the context of his presentation(s), could be perceived as a potential conflict of interest:
| Leonard Calabrese, DO |
|
| |
Consulting: |
Abbott Laboratories; Genentech; Roche |
| |
| |
Teaching
and Speaking: |
Genentech |
The following faculty has indicted he has no relationship with, in the context of his presentation, could be perceived as a potential conflict of interest:
Theodore Pincus, MD |
The Cleveland Clinic Foundation Center for Continuing Education
acknowledges an educational grant for support of this activity from:
Roche Laboratories, Inc.
This CME activity was produced by
The Cleveland Clinic Foundation
Center for Continuing Education and DIME.
CME Disclaimer
The information in this educational activity is provided for general medical education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient’s medical condition. The viewpoints expressed in this CME activity are those of the authors/faculty. They do not represent an endorsement by The Cleveland Clinic Foundation. In no event will The Cleveland Clinic Foundation be liable for any decision made or action taken in reliance upon the information provided through this CME activity.
|
